Sector Alpha

Track where the smart money flows in Indian equities

DashboardWeekly UpdateSector Deep DivesUploadPipelinePE CyclesBrainAboutHow We Research

Data updated weekly. Not financial advice.

sectoralpha · stock story
Pesticides/Agrochemicals →
Home›Stocks›Sharda Cropchem Ltd
SHARDACROPSharda Cropchem LtdPesticides/Agrochemicals
₹885−3.6% 1y

Sharda Cropchem Ltd (SHARDACROP) — share price & stock analysis

Profits have nearly tripled in two years, the price has kept pace — no more, no less.

STEADY GROWTH, FAIRLY PRICEDTrailing NIFTY 500 for 5 weeks
STAGE 2 UPTREND
COMPOUNDERMARGINS EXPANDINGNO REAL DEBTSALES MOMENTUM
DEEP CYCLICALEXPANSION
₹7,984 Cr
Market cap
11.7×
P/E
24.2%
ROE
50th pctile
vs own 10-yr valuation
By Sector Alpha Research · machine-compiled from Screener.in data · Updated 1 July 2026 · Sources: Screener.in company page, NSE quote · Not investment advice
The 30-second answer

Sharda Cropchem Ltd (SHARDACROP) trades at ₹885 as of 1 July 2026, down 3.6% over the past year — trailing NIFTY 500 for 5 weeks. The machine reads this as steady growth, fairly priced: profits have nearly tripled in two years, the price has kept pace — no more, no less. It trades at a P/E of 11.7× (the 50th percentile of its own range); the price is in Stage 2 — advancing, 57 weeks in; the business cycle reads DEEP CYCLICAL / EXPANSION. Fundamentals-momentum score: 89/100 (mostly improving).

Data as of 1 July 2026 · every number traces to its Screener source column · not investment advice.

Key numbers
Market cap
₹7,984 Cr
P/E
11.7×
ROE
24.2%
vs own 10-yr valuation
50th pctile
Book value / share
₹348
EPS (TTM)
₹75.6
10-yr median P/E
17.2×
Revenue (FY26)
₹5,268 Cr
Profit after tax (FY26)
₹681 Cr
Weinstein stage
Stage 2 (57 weeks)
Data as of
1 July 2026
MOMENTUM OF THE FUNDAMENTALS
89/100
MOSTLY IMPROVING
Levels: ROCE 30% — a high-quality engine · effectively no debt · margins near the top of their band
SalesUp 13% YoY — 8 straight growth quarters
MarginsOPM 16.6% → 23.6% in a year
ProfitUp 56% YoY
Cash generationOperating cash ₹604 Cr → ₹656 Cr
Balance sheetDebt is ₹0 per ₹100 of shareholders’ money
Committed ownersPromoters + funds hold 89.1% (a year ago: 89.8%)
DEEP CYCLICAL
Trough
Recovery
Expansion
Peak

Profits swing violently in this business — a 91% peak-to-trough profit collapse. That is what “deep cyclical” means: the same company looks brilliant at the top of its cycle and broken at the bottom.net_profit

Where the clock stands now: earnings sit at 100% of their historical range, margins are near the top of their band, and the market pays mid-range (50th percentile). That reads as EXPANSION — the comfortable middle — but the records are already on the table; from here the bet is that they keep coming.net_profit

5 of the 6 things we track are currently moving the right way — nearly everything is pulling in the same direction.

Where the levels actually stand: ROCE 30% — a high-quality engine; effectively no debt; margins near the top of their band. Momentum says which way things are moving; these say where they are.

Read this number for what it is: it measures the DIRECTION of change, not the quality of the business. A mediocre business getting better scores high here; a great one having a soft quarter scores low. Profit, sales and margins count double.

THE ONE CHART THAT MATTERS

Price and profits are moving together

Since Mar 2016, the stock is up 269% and earnings per share are up 289% — the price has tracked the profits, not run ahead of them.pricettm_eps

The market is paying for delivery, not promises. What you see in earnings is what you get in the price.

Today’s P/E of 11.7× is the middle of its own range against its own 10-year history (50th percentile) — neither a bargain nor a stretch, by its own standards.pe_ratio

Price, earnings per share, and the P/E the market pays₹ · ×valuation_history
5001,000025.0₹ price₹ EPS₹885EPS ₹76P/E ×20.040.0med 17×12×Mar 16Sep 19Mar 23Jul 26
Data: Price, EPS and valuation (sampled — full series in the embedded dataset)
PeriodPrice (₹)EPS (TTM) (₹)P/E (×)
Mar 16224–16.4
Jun 1637519.519.3
Aug 1636019.918.1
Oct 1642220.720.4
Dec 1644419.721.5
Mar 1746921.222.1
May 1755221.125.9
Jul 1748321.422.9
Oct 1745421.421.2
Dec 1746120.422.6
Feb 1839619.520.3
May 1839619.520.3
Jul 1834421.116.3
Sep 1834420.117.1
Nov 1829719.315.4
Feb 1932120.515.7
Apr 1938820.419.0
Jun 1931419.516.1
Sep 1928418.315.5
Nov 1925615.916.1
Jan 2025614.318.0
Apr 2010514.27.4
Jun 20175–12.3
Aug 2030918.916.4
Oct 2027321.612.7
Jan 2127621.612.8
Mar 2131026.211.8
May 2134325.413.5
Aug 2133126.512.5
Oct 2131926.612.0
Dec 2134028.112.1
Mar 2254633.916.1
May 2264638.716.7
Jul 2269337.018.0
Sep 2244336.912.0
Dec 2248234.913.8
Feb 2347835.413.5
Apr 2346435.413.1
Jul 23540–14.8
Sep 2343925.617.2
Nov 23415–19.6
Feb 243849.739.7
Apr 24378–39.1
Jun 24446––
Aug 2456316.434.4
Nov 2481524.133.8
Jan 2572824.130.2
Mar 2557227.121.1
Jun 2578033.823.1
Aug 25957–20.6
Oct 2589046.619.1
Jan 2685550.017.1
Feb 261,19162.719.0
May 261,12262.717.9
Jun 2688875.311.8
Jul 2688575.611.7

Price is the weekly close (₹). EPS is trailing-twelve-month profit per share, anchored on Screener's own snapshots; between snapshots it is filled from price ÷ P/E (an exact identity), and any fill straying more than 18% from the neighbouring snapshots is dropped rather than shown. The lower panel is the P/E — what the market pays per rupee of profit; the dotted line is its long-run median (17.2×).

WHERE THE PRICE IS IN ITS CYCLE

The price is in a confirmed uptrend — 57 weeks and counting

STAGE 2 · ADVANCING · 57 WEEKS

Stock prices move through four repeating stages: basing (1), advancing (2), topping (3) and declining (4). This one is in Stage 2: advancing, 57 weeks in, confirmed.stage

The price sits above its rising 200-day average (₹935 today) — trends like this persist more often than they reverse, which is why the system rides them instead of guessing the top.dma_200

Trailing NIFTY 500 for 5 weeks — relative strength is the market’s live opinion, and right now it is against it.rs_mansfield

What would end it: two Friday closes in a row below the 200-day line. That is the house exit rule — mechanical, no debates.dma_200

Weekly price with its 200-day and 50-day averages — stages shaded₹weinstein_stages
5001,000Price200-DMAStage 2 began · Jun 25Feb 16Aug 19Mar 23Jul 26
Data: Weekly price, moving averages and stage (sampled — full series in the embedded dataset)
PeriodPrice (₹)200-DMA (₹)50-DMA (₹)Stage
Feb 162082622294
May 162892602634
Aug 163603103652
Nov 164063474022
Jan 174763894512
Apr 175184284792
Jul 174834604942
Oct 174544564524
Dec 174504564571
Mar 183694364034
Jun 183954234084
Sep 183964013844
Nov 182973703264
Feb 193523433184
May 193443573712
Aug 193063393114
Nov 192763172884
Jan 202562852544
Apr 201482391684
Jul 202752162064
Oct 202612462702
Dec 202702562712
Mar 213102763062
Jun 213752963322
Sep 213053133272
Nov 213143173213
Feb 225613694692
May 226464706072
Aug 225275476152
Oct 223895154744
Jan 234804884694
Apr 234624814694
Jul 235404955222
Sep 234204754504
Dec 234314524254
Mar 243314243784
Jun 244114043844
Aug 245634565282
Nov 248055406752
Feb 255366156602
May 255255865594
Aug 251,1076948532
Oct 258907808662
Jan 268248098502
Apr 261,0579071,0022
Jun 269149399712
Jul 268859359462
THE LONG ARC

Profits are at an all-time high

Over 12 years, sales went from ₹790 Cr to ₹5,268 Cr (about 17% a year), and profit from ₹111 Cr to ₹681 Cr.revenuenet_profit

Margins took a round trip — down to 9.6% in FY24, back to 20.4% now. The profit growth survived the squeeze.operating_profit

Revenue by year₹ Crannual_results
02,0004,000FY14FY19FY24FY26
Data: Revenue by year
PeriodRevenue (₹ Cr)
FY14790
FY151,061
FY161,222
FY171,399
FY181,707
FY191,998
FY202,003
FY212,396
FY223,580
FY234,045
FY243,163
FY254,320
FY265,268
Profit by year₹ Crannual_results
0250500FY14FY19FY24FY26
Data: Profit by year
PeriodProfit after tax (₹ Cr)
FY14111
FY15123
FY16175
FY17190
FY18191
FY19176
FY20165
FY21229
FY22349
FY23342
FY2432
FY25304
FY26681
OPM % by year%annual_results
10.015.020.0FY14FY19FY24FY26
Data: OPM % by year
PeriodOPM % (%)
FY1420.3
FY1517.2
FY1623.0
FY1723.2
FY1821.3
FY1918.8
FY2017.5
FY2118.8
FY2219.4
FY2316.3
FY249.6
FY2514.2
FY2620.4
CHAPTER 1 · THE ENGINE

Sales grew 13% last quarter — growth every single quarter for over 2 years

Revenue — the money that comes in from customers, before any costs.

Mar 26 sales were ₹2,065 Cr, up 13% on the same quarter last year.revenue

That makes 8 quarters of growth in a row — this is a trend, not a blip.revenue

Quarterly sales₹ Crquarterly_results
01,0002,000YoY %+23+34+47+39+26+39Jun 23Jun 24Jun 25Mar 26
Data: Quarterly sales
PeriodRevenue (₹ Cr)YoY growth (%)
Jun 23638–
Sep 23581–
Dec 23632–
Mar 241,312–
Jun 2478523.0
Sep 2477733.7
Dec 2492947.0
Mar 251,82939.4
Jun 2598525.5
Sep 2592919.6
Dec 251,28938.8
Mar 262,06512.9
WATCH →If quarterly growth slips below 6%, the story weakens.
CHAPTER 2 · THE TAKE

Margins are widening — 17% → 24% in a year

Margins — the share of every ₹100 of sales kept as profit. Gross (after raw materials), operating (after running costs), net (after everything).

Of every ₹100 of sales, the company keeps ₹23.6 as operating profit (a year ago it kept ₹16.6).opm_pct

Zoom out and this is the page's quiet hero: annual operating margin bottomed at 9.6% in FY24 and has been rebuilt to 20.4% — that recovery, not sales alone, is what powers the profit growth elsewhere on this page.operating_profit

The gross margin moved the same way (30% → 37%), so this is about input costs and pricing power — the raw-material equation improved.gpm_pctopm_pct

Three margins, quarterly%margin_trends
0.020.040.0GrossOperatingNetJun 23Jun 24Jun 25Mar 26
Data: Three margins, quarterly
PeriodGross (%)Operating (%)Net (%)
Jun 238.7-9.3-13.9
Sep 2325.13.7-4.8
Dec 2326.211.00.7
Mar 2434.619.410.9
Jun 2429.29.83.5
Sep 2427.611.55.5
Dec 2432.712.33.4
Mar 2529.816.611.1
Jun 2535.521.914.5
Sep 2534.514.38.0
Dec 2534.918.711.3
Mar 2637.323.615.4
WATCH →Two consecutive quarters of margin decline would break this trend.
CHAPTER 3 · THE BOTTOM LINE

Profit exploded 56% — mostly from keeping more of each sale

PAT (profit after tax) — what is left for shareholders after every cost, interest and tax.

Mar 26 profit after tax was ₹319 Cr, up 56% year on year.net_profit

Quarterly profit after tax₹ Crquarterly_results
0200YoY %+130+250+520+43+430+76+368+56Jun 23Jun 24Jun 25Mar 26
Data: Quarterly profit after tax
PeriodPAT (₹ Cr)YoY growth (%)
Jun 23-89.0–
Sep 23-28.0–
Dec 235.0–
Mar 24143–
Jun 2427.0130.3
Sep 2442.0250.0
Dec 2431.0520.0
Mar 2520442.7
Jun 25143429.6
Sep 2574.076.2
Dec 25145367.7
Mar 2631956.4
Where the profit change came from (Mar 25 → Mar 26)₹ Cr
204+39+145−3−15−51319PAT Mar 25More salesFattermarginsOther incomeDepreciationTaxPAT Mar 26

The single biggest driver was keeping more of each sale.

Data: Where the profit change came from (Mar 25 → Mar 26)
ComponentEffect (₹ Cr)
PAT Mar 25204
More sales+39
Fatter margins+145
Other income−3
Depreciation−15
Tax−51
PAT Mar 26319
CHAPTER 4 · THE ACID TEST

The profits are real — they turn into cash

Operating cash flow (CFO) — the cash that actually arrived, vs PAT, the profit accounting reports. Annual figures.

Over the last 5 profitable years, the business reported ₹1,708 Cr of profit and collected ₹2,196 Cr of operating cash — about 129% conversion.operating_cash_flownet_profit

When cash tracks profit this closely, the earnings need no asterisk.

Cash collected vs profit reported (annual)₹ Crcash_flow
0200400600Operating cash flowProfit after taxFY14FY19FY24FY26
Data: Cash collected vs profit reported (annual)
PeriodOperating cash flow (₹ Cr)Profit after tax (₹ Cr)
FY14156111
FY1546.0123
FY16197175
FY17181190
FY1817.0191
FY19556176
FY20146165
FY21246229
FY22267349
FY23328342
FY2434132.0
FY25604304
FY26656681
CHAPTER 5 · THE PIPELINE

The cash cycle is stable

Working capital — days of sales locked up in inventory and unpaid bills. Screener reports this yearly, so this chart is annual.

One rupee now takes about 125 days to go out the door as materials and come back as collected cash.cash_conversion_cycle

Days of cash locked up (annual)daysratios
50100150200Customers owe (debtor days)Stock on shelf (inventory days)We owe suppliers (payable days)FY14FY19FY24FY26
Data: Days of cash locked up (annual)
PeriodCustomers owe (debtor days) (days)Stock on shelf (inventory days) (days)We owe suppliers (payable days) (days)
FY1418557.0146
FY1515672.0117
FY1618574.0179
FY17175117186
FY18191169202
FY1914896.0167
FY20180100180
FY21177117180
FY22157130172
FY23165145176
FY24173155144
FY25165117158
FY26166121162
CHAPTER 6 · THE BUILD

The asset base keeps compounding — this company builds

Capex — money spent on plants, machines and buildings. Gross block is what exists; CWIP (capital work-in-progress) is what is being built. Annual.

The productive asset base has gone from ₹64.0 Cr (FY14) to ₹1,236 Cr.fixed_assetscwip

The build is self-funded: the last 3 years' investing outflow (₹1,402 Cr) fits inside the operating cash the business generated (₹1,601 Cr).investing_cash_flowoperating_cash_flow

Assets in place vs under construction (annual)₹ Crbalance_sheet
05001,000Fixed assetsUnder construction (CWIP)FY14FY19FY24FY26
Data: Assets in place vs under construction (annual)
PeriodFixed assets (₹ Cr)Under construction (CWIP) (₹ Cr)
FY1464.0133
FY1588.0149
FY16130210
FY17210232
FY18226360
FY19372220
FY20416161
FY21544131
FY22592212
FY23668204
FY24708283
FY25750291
FY261,2360.0
CHAPTER 7 · SURVIVAL

Almost no debt — this company cannot be killed by a bad year

Debt-to-equity — borrowings against shareholders’ money. Computed from the balance sheet. Annual.

For every ₹100 shareholders have put in (and left in), the company has borrowed ₹0 — total borrowings have shrunk from ₹40.0 Cr to ₹0.0 Cr over the window.borrowings

Total borrowings (annual)₹ Crbalance_sheet
0100FY14FY19FY24FY26
Data: Total borrowings (annual)
PeriodBorrowings (₹ Cr)
FY1440.0
FY1538.0
FY162.0
FY170.0
FY18170
FY190.0
FY200.0
FY2181.0
FY2247.0
FY233.0
FY2418.0
FY258.0
FY260.0
Debt vs shareholders’ money (annual)xbalance_sheet
00.050.10.15FY14FY19FY24FY26
Data: Debt vs shareholders’ money (annual)
PeriodDebt ÷ equity (x)
FY140.1
FY150.1
FY160.0
FY170.0
FY180.2
FY190.0
FY200.0
FY210.1
FY220.0
FY230.0
FY240.0
FY250.0
FY260.0
CHAPTER 8 · THE ENGINE ROOM

Every ₹100 kept in the business now earns ₹30 — and the number is rising

ROCE — profit earned per ₹100 of capital used. ROE — the same, per ₹100 of shareholders’ money alone. Annual.

Return on capital employed is 30.0% (a year ago: 16.0%). This is the single best test of business quality: what the company earns on the money it keeps.roce_pct

Rising returns on capital while growing is the rarest combination in investing — it means the new projects earn more than the old ones.roce_pct

Returns on capital (annual)%ratios
10.020.030.0ROCEFY14FY19FY24FY26
Data: Returns on capital (annual)
PeriodROCE (%)
FY1428.0
FY1527.0
FY1636.0
FY1732.0
FY1827.0
FY1923.0
FY2018.0
FY2121.0
FY2226.0
FY2321.0
FY244.0
FY2516.0
FY2630.0
CHAPTER 9 · WHO OWNS IT

The owners aren’t moving

Shareholding — who owns the company: founders (promoters), foreign funds (FII), domestic funds (DII).

Promoters hold 74.8%, essentially unchanged. Foreign funds own 4.6%, domestic funds 9.7%.promoters_pctfiis_pctdiis_pct

Institutions buying while the story develops is the market’s quiet vote of confidence — they meet management, you don’t.

Meanwhile domestic funds have been the sellers — from 12.8% to 9.7% over the window. Someone on the other side of the table disagrees; both sides count.diis_pct

Who holds the shares, quarterly%shareholding
Promoters74.8% → 74.8% · flat
74.074.575.075.5Jun 23Jun 24Jun 25Mar 26
Foreign funds2.0% → 4.6% · up 2.6 pts
2.03.04.05.0Jun 23Jun 24Jun 25Mar 26
Domestic funds12.8% → 9.7% · down 3.1 pts
9.010.011.012.013.0Jun 23Jun 24Jun 25Mar 26
Data: Who holds the shares, quarterly
PeriodPromoters (%)Foreign funds (%)Domestic funds (%)
Jun 2374.82.012.8
Sep 2374.82.012.3
Dec 2374.82.112.4
Mar 2474.82.112.4
Jun 2474.82.012.9
Sep 2474.82.512.8
Dec 2474.83.810.1
Mar 2574.84.710.3
Jun 2574.85.59.4
Sep 2574.85.39.3
Dec 2574.84.210.0
Mar 2674.84.69.7
WHAT IS NOT HAPPENING
  • Promoters are not selling. Their stake has moved 0.1 points or less in 8 quarters — it sits at 74.8%.promoters_pct
THE VERDICT

Worth studying deeper — with eyes open

The numbers lean positive, and the price is roughly fair to the delivery so far.

Best thing in the data: returns on capital rising (16.0% → 30.0%).roce_pct

One dissent worth hearing: our technicals lens reads negative — “Technicals bearish with 57% confidence”. When a lens disagrees with the committee, it is usually pointing at the thing that breaks first.

The machine committee — 7 independent readsSTUDY DEEPER · 72%
Earnings patternPOSITIVE85% · w21
Valuation cyclePOSITIVE100% · w19
CatalystsNEUTRAL40% · w14
Quality & safetyNEUTRAL42% · w14
TechnicalsNEGATIVE57% · w12
ValuationPOSITIVE90% · w10
Growth at a pricePOSITIVE78% · w10
One model disagrees — the Technicals lens reads this stock as NEGATIVE (57% confidence): “Technicals bearish with 57% confidence”
Business quality7.4/10
Management5.8/10
7-model research readSTUDY DEEPER · 72% confidence
WHAT WOULD CHANGE THIS VIEWTwo quarters of margins reversing would kill this story.

Machine-written research from Screener data — every number traces to its source column. Sector Alpha is not a SEBI-registered investment adviser; nothing here is a recommendation to buy or sell. Not investment advice.

More Pesticides/Agrochemicals stocks
UPL LtdP I Industries LtdSumitomo Chemical India LtdBayer CropScience LtdJubilant Ingrevia LtdNACL Industries LtdAll Pesticides/Agrochemicals stocks →
Frequently asked questions

Straight answers from the data

What does Sharda Cropchem Ltd do?

Sharda Cropchem is principally engaged in export of agrochemicals (technical grade and formulations) and non-agro products such as conveyor belts, rubber belts/sheets, dyes and dye intermediates to various countries across the world. It is listed in the Pesticides/Agrochemicals sector with a market capitalisation of ₹7,984 Cr.

What is Sharda Cropchem Ltd's share price?

As of 1 July 2026, Sharda Cropchem Ltd trades at ₹885, down 3.6% over the past year, with a market capitalisation of ₹7,984 Cr. Trailing NIFTY 500 for 5 weeks. Prices are weekly closes from Screener data; this page refreshes with each weekly update.

What is Sharda Cropchem Ltd's share price target?

Sector Alpha does not publish broker-style price targets. Our discounted-cash-flow model estimates Sharda Cropchem Ltd's intrinsic value at ₹2,983 per share under base assumptions (bear ₹1,076, bull ₹2,983), against the current price of ₹885 — a 230% margin of safety. The current price already implies roughly 4% annual earnings growth. These are model estimates, not forecasts — treat them as one input alongside the valuation history below, not as a target.

Is Sharda Cropchem Ltd stock overvalued or undervalued?

Sharda Cropchem Ltd trades at a P/E of 11.7× — the 50th percentile of its own 10.3-year trading range (median 17.2×), which is around the middle of its own historical range. Price and profits are moving together. Since Mar 2016, the stock is up 269% and earnings per share are up 289% — the price has tracked the profits, not run ahead of them.

What did Sharda Cropchem Ltd report in its latest quarterly results?

In its most recent reported quarter (Q4 FY26, quarter ended March 2026): Mar 26 sales were ₹2,065 Cr, up 13% on the same quarter last year. Mar 26 profit after tax was ₹319 Cr, up 56% year on year. Figures are from Screener-scraped quarterly filings; the page updates when the next quarter is filed.

Is Sharda Cropchem Ltd growing?

Sales grew 13% last quarter — growth every single quarter for over 2 years. Mar 26 sales were ₹2,065 Cr, up 13% on the same quarter last year.

Are Sharda Cropchem Ltd's profits growing?

Profit exploded 56% — mostly from keeping more of each sale. Mar 26 profit after tax was ₹319 Cr, up 56% year on year.

What are Sharda Cropchem Ltd's operating margins?

Margins are widening — 17% → 24% in a year. In the most recent quarter, of every ₹100 of sales, the company keeps ₹23.6 as operating profit (a year ago it kept ₹16.6).

What is Sharda Cropchem Ltd's long-term growth record?

Revenue grew from ₹790 Cr in FY14 to ₹5,268 Cr in FY26 — a 17.1% compound annual growth rate over 12 years. Profit after tax compounded at 16.3% over the same period (₹111 Cr → ₹681 Cr).

Is Sharda Cropchem Ltd stock in an uptrend?

The price is in a confirmed uptrend — 57 weeks and counting. Sharda Cropchem Ltd is in Stage 2 — advancing, 57 weeks in (confirmed). Stages follow Stan Weinstein's four-phase read of weekly price against the 200-day average: basing (1), advancing (2), topping (3), declining (4).

Is Sharda Cropchem Ltd beating the NIFTY 500?

No — trailing NIFTY 500 for 5 weeks, as of 1 July 2026. Relative strength is measured weekly against the NIFTY 500 (Mansfield RS): a positive reading means the stock has outperformed the index over the trailing window, week after week.

Where is Sharda Cropchem Ltd in its business cycle?

The data reads Sharda Cropchem Ltd as a deep cyclical business currently in its expansion phase — earnings at an all-time high for this company, valuation at the 50th percentile. Profits swing violently in this business — a 91% peak-to-trough profit collapse. That is what “deep cyclical” means: the same company looks brilliant at the top of its cycle and broken at the bottom.

Who owns Sharda Cropchem Ltd — what is the promoter holding?

Promoters hold 74.8%, essentially unchanged. Foreign funds own 4.6%, domestic funds 9.7%. Institutions buying while the story develops is the market’s quiet vote of confidence — they meet management, you don’t. Shareholding is from Screener's quarterly filings data.

Does Sharda Cropchem Ltd have too much debt?

Almost no debt — this company cannot be killed by a bad year. For every ₹100 shareholders have put in (and left in), the company has borrowed ₹0 — total borrowings have shrunk from ₹40.0 Cr to ₹0.0 Cr over the window.

What is the bull case for Sharda Cropchem Ltd?

Profits have nearly tripled in two years, the price has kept pace — no more, no less. Best thing in the data: returns on capital rising (16.0% → 30.0%). Sales grew 13% last quarter — growth every single quarter for over 2 years.

What is the bear case for Sharda Cropchem Ltd — what could break the story?

Two quarters of margins reversing would kill this story. The nearest-term thing to watch: if quarterly growth slips below 6%, the story weakens. This falsification condition is stated up front so the thesis can be checked against incoming quarters, not defended after the fact.

Is Sharda Cropchem Ltd a stock worth studying right now?

Sector Alpha does not publish buy or sell recommendations — this is a research read, not advice. What the data says: worth studying deeper — with eyes open. The numbers lean positive, and the price is roughly fair to the delivery so far. Across the 7-model scorecard the composite research signal is study deeper at 72% confidence. This is machine-written research compiled from Screener data — every number traces to its source — and it is not investment advice. Do your own diligence.

Generated from Screener data · 12 sources · why_traces/1.0 + story/1.2
details
generated 2026-07-03 11:21 · 6 material moves detected
sources: screener_company_info, screener_quarterly_results, screener_annual_results, screener_valuation_history, screener_shareholding, screener_cash_flow, screener_ratios, screener_balance_sheet, screener_margin_trends, weinstein_stages, agent_scores, stock_timelines